SCHEMBL4616546

SCHEMBL4616546

COc1ccc(Br)cc1CCNS(=O)(=O)c1cccc(S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.55
HTT P42858 2/20 0.53
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HTR6 P50406 3/20 0.50
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
PKM P14618 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6103330 0.89 SFRP1 (0.63) SFRP1HTTALDH1A1KDM4ECYP1A2
SCHEMBL4616794 0.88 SFRP1 (0.56) SFRP1HTTALDH1A1KDM4ECYP1A2
SCHEMBL4616713 0.87 CA12 (0.58) SFRP1HTTALDH1A1KDM4ECYP1A2
SCHEMBL4616734 0.85 SFRP1 (0.56) SFRP1HTTALDH1A1KDM4ECYP1A2
SCHEMBL4617228 0.81 SFRP1 (0.53) SFRP1HTTALDH1A1KDM4ECYP1A2
SCHEMBL6104071 0.81 HTT (0.81) SFRP1HTTALDH1A1SMN1; SMN2MEN1
SCHEMBL27733317 0.80 HTT (0.65) SFRP1HTTALDH1A1SMN1; SMN2PKM
SCHEMBL4619413 0.80 SFRP1 (0.66) SFRP1HTTALDH1A1KDM4ECYP1A2
SCHEMBL4619015 0.79 SFRP1 (0.51) SFRP1ALDH1A1KDM4ESMN1; SMN2HTR6
SCHEMBL4619239 0.79 SFRP1 (0.51) SFRP1HTTALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885HTT 4703/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.